Semaglutide Weight Loss Dallas
Physician-guided GLP-1 weight management with dual board-certified medical oversight, body-composition monitoring and a plan designed around fat loss—not just a lower number on the scale.
Semaglutide is the active medication in FDA-approved products including Wegovy®, Ozempic® and Rybelsus®. For appropriate patients, semaglutide can reduce appetite, increase satiety and support substantial weight loss. At Sanjiva Medical Spa, treatment is guided by a physician board certified in both Internal Medicine and Obesity Medicine.
What Is Semaglutide?
Semaglutide is not simply an “appetite shot.” It is a prescription medication with meaningful metabolic effects, specific indications, contraindications and potential side effects. For weight management, it is used alongside nutrition, physical activity and behavioral changes rather than as a stand-alone solution.
Wegovy, Ozempic & Rybelsus: Are They All Semaglutide?
Wegovy®
Semaglutide available in injectable and oral formulations. FDA-approved uses include chronic weight management in eligible patients; Wegovy injection also has additional cardiovascular and MASH indications.
Wegovy HD
A higher 7.2 mg weekly injectable dose approved in 2026 for weight loss and long-term maintenance of weight reduction in certain adults.
Ozempic®
Semaglutide used for type 2 diabetes and specified cardiovascular and kidney-risk indications. It is not the semaglutide brand specifically approved for chronic weight management.
Rybelsus®
Oral semaglutide with FDA-approved indications for type 2 diabetes. Brand choice should follow the patient’s actual medical indication rather than internet popularity.
How Much Weight Can You Lose With Semaglutide?
For someone starting at 200 pounds, 15% represents approximately 30 pounds. But scale weight tells only part of the story.
Our Goal: Lose Fat, Protect Muscle
A patient who loses 25 pounds primarily from fat has achieved something very different from a patient who loses the same 25 pounds with substantial lean-mass loss.
Body-composition analysis can track skeletal muscle mass, body-fat percentage and visceral fat rather than relying on body weight alone.
Who May Be a Candidate for Semaglutide?
At Sanjiva, the first question is not simply, “Can I get semaglutide?” It is: What is the safest and most effective strategy for your health, body composition and long-term goals?
Why Choose Sanjiva for Semaglutide in Dallas?
For patients interested in a broader medical optimization approach beyond GLP-1 weight management, learn about Sanjiva’s physician-guided peptide therapy, body-composition monitoring and individualized treatment planning.
Semaglutide Side Effects & Safety
Current Wegovy prescribing information includes a boxed warning regarding thyroid C-cell tumors observed in rodents and contraindicates use in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Other important considerations include pancreatitis, gallbladder disease, dehydration-related kidney injury, severe gastrointestinal reactions and hypersensitivity.
Semaglutide delays gastric emptying. Patients should make surgeons and anesthesia teams aware of GLP-1 therapy before procedures requiring anesthesia or deep sedation.
Semaglutide vs Tirzepatide: Which Is Better?
The choice should be based on the patient’s medical history, goals, prior response, side effects, contraindications, access and clinical indication—not simply which medication is trending online.
What About Compounded Semaglutide?
In 2026, FDA also proposed excluding semaglutide from the 503B bulks list after finding no clinical need for outsourcing facilities to compound it from bulk drug substances. Individual compounding circumstances can be legally complex, but patients should understand that compounded semaglutide and FDA-approved Wegovy/Ozempic are not equivalent regulatory categories.
Semaglutide Weight Loss Near You in Dallas
Looking for a semaglutide doctor near you in Dallas? Sanjiva Medical Spa is located at 5633 W Lovers Lane, Dallas, TX 75209, convenient to University Park, Highland Park, Preston Hollow, Bluffview, Uptown Dallas, Oak Lawn, Greenway Parks and surrounding neighborhoods.
Our differentiator is not simply access to a prescription. It is medical weight management led by a physician board certified in both Internal Medicine and Obesity Medicine, combined with body-composition monitoring and individualized treatment planning.
Frequently Asked Questions About Semaglutide
Is semaglutide the same as Ozempic?
Semaglutide is the active medication in Ozempic. Ozempic is a specific FDA-approved semaglutide product with indications centered on type 2 diabetes and certain cardiovascular and kidney outcomes. Wegovy is the semaglutide brand specifically used for chronic weight management in eligible patients.
Is Wegovy semaglutide?
Yes. Wegovy contains semaglutide and is FDA approved for chronic weight management in qualifying patients. Wegovy is available in injectable and oral formulations, and a higher-dose Wegovy HD injection was approved in 2026 for certain adults.
How much weight can I lose on semaglutide?
In the landmark STEP 1 trial, adults with overweight or obesity treated with semaglutide 2.4 mg plus lifestyle intervention lost about 15% of their starting body weight on average over 68 weeks. Individual results vary.
How quickly does semaglutide work?
Appetite and satiety changes may occur relatively early, but meaningful weight loss usually develops progressively over months as the medication is titrated and combined with nutrition, activity and behavioral changes.
Does semaglutide cause muscle loss?
Weight loss from any method can include lean mass as well as fat. Adequate protein, resistance training and body-composition monitoring can make muscle preservation an explicit part of the treatment strategy.
Is semaglutide a peptide?
Yes. Semaglutide is a peptide-based GLP-1 receptor agonist designed to mimic the activity of the naturally occurring GLP-1 hormone while lasting much longer in the body.
Is compounded semaglutide FDA approved?
No. Compounded semaglutide is not FDA approved. FDA does not review compounded medications for safety, effectiveness or manufacturing quality before marketing in the same manner as FDA-approved drugs.
Do I need to stay on semaglutide forever?
Not necessarily, but obesity is a chronic disease and weight regain can occur after GLP-1 medication is discontinued. Maintenance planning should be individualized and discussed before reaching goal weight rather than treated as an afterthought.
Where can I find semaglutide weight loss near me in Dallas?
Sanjiva Medical Spa provides physician-guided medical weight management at 5633 W Lovers Lane in Dallas, near University Park, Highland Park, Preston Hollow, Bluffview, Uptown Dallas and Oak Lawn.
Medical Weight Loss Is More Than a Prescription
Semaglutide can be a powerful medical tool, but the goal is not simply to eat less and watch the scale fall. Sanjiva’s approach focuses on fat loss, muscle preservation, body composition and a realistic long-term strategy.
Praveen Guntipalli, MD, FACP
Board Certified, American Board of Internal Medicine
Board Certified, American Board of Obesity Medicine
Selected Medical References
Key sources include current FDA prescribing information for Wegovy, FDA regulatory updates on semaglutide compounding, and the STEP clinical-trial program evaluating semaglutide for chronic weight management.
- FDA: Wegovy (semaglutide) Prescribing Information, 2026
- FDA: Wegovy HD 7.2 mg Approval, March 2026
- FDA: 2026 GLP-1 Compounding Policy Update
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384:989-1002.